Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orsini Specialty Pharmacy is a leading provider of comprehensive pharmacy services dedicated to patients with rare and orphan diseases. The company specializes in managing complex, high-cost therapies that require intensive clinical monitoring and patient support, such as those for hemophilia, lysosomal storage disorders, and neuromuscular conditions. Orsini provides a high-touch care model that includes nationwide dispensing, clinical nursing services, and assistance with insurance navigation and financial aid. By maintaining a focus on limited-distribution drugs, the company serves as a critical link between biopharmaceutical manufacturers and patients with unmet medical needs. In 2024, Orsini was acquired by CarelonRx, a subsidiary of Elevance Health, to further integrate specialty pharmacy services into broader healthcare management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orsini Pharmaceutical Services.